La Roche-Posay… a bet­ter life for on­col­ogy pa­tients

Malta Independent - - LIFESTYLE & CULTURE -

La Roche-Posay’s long­stand­ing mis­sion is to aid peo­ple with sen­si­tive or fragile skin, to im­prove their qual­ity of life, and it has worked along­side der­ma­tol­o­gists for more than a decade in the de­tec­tion and pre­ven­tion of skin can­cer. La Roche-Posay is com­mit­ted to ad­vanc­ing re­search into the cu­ta­neous side­ef­fects of chemo­ther­apy and ra­dio­ther­apy so as to of­fer relief for can­cer pa­tients.

To­day, bil­lions of peo­ple across the world are af­fected by can­cer, and while ther­a­pies are nec­es­sary, they can have no­tice­able ef­fects on the body, and have a gen­uine im­pact on the pa­tient’s qual­ity of life. 2 in 3 can­cer pa­tients suf­fer from cu­ta­neous side-ef­fects rang­ing from light­sen­si­tive or ir­ri­tated skin to more se­vere symp­toms and dis­or­ders.

In line with this mis­sion, Pro­health, the exclusive dis­trib­u­tors for La Roche-Posay, held a sci­en­tific evening for Spe­cial­ists, Der­ma­tol­o­gists, and other Health­care pro­fes­sion­als work­ing within the field of On­col­ogy on 20 October 2016 at Villa Ar­rigo.

The evening opened with an in­ter­est­ing and highly in­for­ma­tive pre­sen­ta­tion on Bar­rier Pro­tec­tion un­der Ad­ju­vant Chemo­ther­apy for Breast Can­cer given by Prof. Diana Lüft­ner from the Ger­man So­ci­ety for Hae­ma­tol­ogy and Med­i­cal On­col­ogy. The talk aimed to high­light the im­por­tance of deal­ing with cu­ta­neous side-ef­fects so as to im­prove the qual­ity of life of our On­col­ogy pa­tients.

In co­or­di­na­tion with this event, Pro­health has also do­nated €3000 in La Roche-Posay prod­ucts to the Sir An­thony Mamo On­col­ogy Cen­tre, and to the Chil­dren’s On­col­ogy Ward at Mater Dei Hospi­tal. Th­ese will be dis­trib­uted to pa­tients by the med­i­cal staff.

Newspapers in English

Newspapers from Malta

© PressReader. All rights reserved.